SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-22-022654
Filing Date
2022-06-15
Accepted
2022-06-15 18:01:04
Documents
2
Period of Report
2022-06-08

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 6928
2 EX-24 DOCUMENT attachment1.htm EX-24 4761
  Complete submission text file 0000899243-22-022654.txt   13210
Mailing Address C/O FULCRUM THERAPEUTICS, INC. 26 LANDSDOWNE STREET CAMBRIDGE MA 02139
Business Address
Collins James J. (Reporting) CIK: 0001779269 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40440 | Film No.: 221018770

Mailing Address 2 CORPORATE DRIVE, FIRST FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 2 CORPORATE DRIVE, FIRST FLOOR SOUTH SAN FRANCISCO CA 94080 (650) 382-3281
Senti Biosciences, Inc.\ (Issuer) CIK: 0001854270 (see all company filings)

IRS No.: 862437900 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)